Jane Street Group, LLC G1 Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

A detailed history of Jane Street Group, LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 64,916 shares of GTHX stock, worth $464,149. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,916
Previous 333,572 80.54%
Holding current value
$464,149
Previous $1.44 Million 89.73%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$2.2 - $4.98 $591,043 - $1.34 Million
-268,656 Reduced 80.54%
64,916 $148,000
Q1 2024

May 15, 2024
BUY
$2.1 - $4.83 $233,041 - $535,994
110,972 Added 49.85%
333,572 $1.44 Million
Q4 2023

Feb 14, 2024
BUY
$1.12 - $3.73 $237,669 - $791,524
212,205 Added 2041.41%
222,600 $678,000
Q3 2023

Nov 14, 2023
BUY
$1.22 - $2.67 $12,681 - $27,754
10,395 New
10,395 $14,000
Q1 2023

May 15, 2023
SELL
$2.57 - $8.16 $195,535 - $620,845
-76,084 Reduced 57.59%
56,040 $150,000
Q4 2022

Feb 14, 2023
BUY
$5.19 - $13.5 $262,074 - $681,696
50,496 Added 61.86%
132,124 $717,000
Q3 2022

Nov 14, 2022
BUY
$5.17 - $16.99 $301,840 - $991,927
58,383 Added 251.16%
81,628 $1.02 Million
Q3 2022

Nov 14, 2022
BUY
$5.17 - $16.99 $301,840 - $991,927
58,383 Added 251.16%
81,628 $1.02 Million
Q2 2022

Aug 16, 2022
SELL
$4.04 - $8.51 $50,863 - $107,140
-12,590 Reduced 35.13%
23,245 $115,000
Q1 2022

May 17, 2022
SELL
$7.6 - $11.02 $108,087 - $156,726
-14,222 Reduced 28.41%
35,835 $272,000
Q4 2021

Feb 15, 2022
SELL
$10.16 - $16.17 $150,164 - $238,992
-14,780 Reduced 22.8%
50,057 $511,000
Q3 2021

Nov 16, 2021
BUY
$13.16 - $22.47 $331,447 - $565,929
25,186 Added 63.52%
64,837 $870,000
Q2 2021

Aug 16, 2021
SELL
$19.57 - $26.32 $1.57 Million - $2.11 Million
-80,000 Reduced 66.86%
39,651 $870,000
Q1 2021

May 18, 2021
BUY
$17.58 - $32.59 $1.64 Million - $3.03 Million
93,056 Added 349.9%
119,651 $2.88 Million
Q4 2020

Feb 17, 2021
BUY
$10.99 - $20.4 $57,906 - $107,487
5,269 Added 24.71%
26,595 $478,000
Q3 2020

Nov 17, 2020
BUY
$11.55 - $23.75 $246,315 - $506,492
21,326 New
21,326 $247,000
Q4 2019

Feb 14, 2020
SELL
$20.54 - $31.0 $284,417 - $429,257
-13,847 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$22.78 - $40.58 $315,434 - $561,911
13,847 New
13,847 $315,000
Q4 2018

Feb 15, 2019
SELL
$16.51 - $51.33 $236,291 - $734,634
-14,312 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$43.15 - $67.97 $617,562 - $972,786
14,312 New
14,312 $748,000

Others Institutions Holding GTHX

# of Institutions
9
Shares Held
3.71M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email